Drug intelligence / Profile preview

sodium hyaluronate (Avizor)

Development stage
Unknown
Lead developer
Avizor
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

AVIZOR LACRIFRESH is a brand of lubricating ophthalmic solutions (artificial tears) developed by the Spanish company Avizor and distributed in various markets, including Vietnam by TV TPI. The product line is primarily designed to alleviate symptoms of dry eye syndrome, ocular irritation, and eye fatigue caused by environmental factors, prolonged screen use, or contact lens wear. The flagship formulation, Lacrifresh Moisture, contains 0.1% sodium hyaluronate, a naturally occurring viscoelastic polysaccharide that mimics the properties of the natural tear film to stabilize the precorneal layer and provide long-lasting hydration. Other variants in the line include Lacrifresh Comfort (containing povidone) and Lacrifresh Ocu-Dry (containing higher concentrations of sodium hyaluronate, such as 0.2% or 0.3%). These products are often registered as medical devices or over-the-counter pharmaceutical lubricants depending on the jurisdiction.

Brand names
AVIZOR LACRIFRESHLacrifresh MoistureLacrifresh ComfortLacrifresh Ocu-Dry
Other names
hyaluronic acidsodium hyaluronate ophthalmic
02

Targets

Fibrin (Factor Ia)Ocular surface mucin layerCD44 (CD44 antigen)

Beyond the preview

Go deeper on sodium hyaluronate (Avizor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate (Avizor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call